Modelling interpretable patient-level representations from structured and simple multimodal data
Year: 2026
Type: preprint
Abstract: Patient cohort profiling increasingly includes structured views for multiple modalities, such as single-cell RNA sequencing, spatial transcriptomics or proteomics, and histology, each providing multiple subobservations per patient, including single cells, spatial spots or patches. To model such data along with simple patient-level views, current multimodal integration methods typically rely on separately precomputed summaries and fail to fully leverage information in structured views. Here we present FACTMx, a variational framework that jointly models structured and simple views to learn interpretable patient-level representations. FACTMx couples latent patient factors with subobservation clustering and per-patient component proportions, enabling direct interpretation and downstream association analyses. The framework supports different structured-view mixture assumptions, including topic- and Gaussian-structured data, while retaining modular encoder-decoder parameterisations. In simulations spanning sparse and dense dependencies and multiple noise regimes, FACTMx improved reconstruction, integration and recovery of structured components relative to previous methods. Applied to non-small cell lung cancer cohorts, FACTMx captured survival-associated latent signals linked to immune microenvironments, gene expression pathways and spatially coherent histological patterns. In a longitudinal coronary syndrome cohort, FACTMx highlighted an outcome-associated axis connected to ejection-fraction change, immune cell states, soluble mediators and cardiac injury markers. These results support joint structured-simple modelling for interpretable multimodal patient stratification.
Institutions: University of Warsaw, Medical University of Warsaw, Warsaw University of Technology, University of Zurich, ETH Zurich, Institute of Molecular Health Sciences, SIB Swiss Institute of Bioinformatics, Institut Gustave Roussy, European Organisation for Research and Treatment of Cancer, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), Centre Hospitalier Universitaire Vaudois, Helmholtz Munich
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7208747540
